116 related articles for article (PubMed ID: 9614683)
1. Mibefradil: a new twist to the calcium channel antagonist.
Lynn MM
Nurse Pract; 1998 May; 23(5):100, 102-4, 106-7. PubMed ID: 9614683
[No Abstract] [Full Text] [Related]
2. Mibefradil (posicor).
Giles TD
Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
[No Abstract] [Full Text] [Related]
3. [Mibefradil: a new class calcium inhibitor].
Internist (Berl); 1996 Oct; 37(10 Suppl Mibefradil):1-8. PubMed ID: 9402420
[No Abstract] [Full Text] [Related]
4. [Introducing mibefradil--a new T-calcium channel blocker].
Internist (Berl); 1997 Dec; 38(12 Suppl Mibefradil):1-4. PubMed ID: 9437250
[No Abstract] [Full Text] [Related]
5. [Evolution of antihypertensive therapy with calcium antagonists: the new molecules].
Pirrelli A; Vulpis V
Cardiologia; 1998 Apr; 43(4):357-64. PubMed ID: 9659793
[No Abstract] [Full Text] [Related]
6. [Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Wagner J; Ritz E
Dtsch Med Wochenschr; 1998 Apr; 123(17):547. PubMed ID: 9601479
[No Abstract] [Full Text] [Related]
7. Steady-state trough plasma mibefradil concentrations and correlation to blood pressure response in hypertensive patients with chronic renal disease.
Pordy R; Woittiez A
Int J Clin Pharmacol Res; 1998; 18(3):105-8. PubMed ID: 9825266
[TBL] [Abstract][Full Text] [Related]
8. [Mibefradil opens up a new class of calcium antagonists. Glasgow, 23 June 1996].
Dtsch Med Wochenschr; 1996 Sep; 121(39 Suppl):1-4. PubMed ID: 9212757
[No Abstract] [Full Text] [Related]
9. Mibefradil--a new calcium-channel blocker.
Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
[No Abstract] [Full Text] [Related]
10. [The pharmacological and clinical outlook for mibefradil--a new selective T-type calcium channel antagonist].
Eliseev OM
Ter Arkh; 1998; 70(8):87-8. PubMed ID: 9841457
[No Abstract] [Full Text] [Related]
11. Capillary blood cell velocity in finger nailfold: effect of enalapril and mibefradil in patients with mild to moderate hypertension.
Martina B; Frach B; Surber C; Drewe J; Battegay E; Gasser P
Microvasc Res; 1999 Mar; 57(2):94-9. PubMed ID: 10049657
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension.
Oparil S
Am J Hypertens; 1998 Apr; 11(4 Pt 3):88S-94S. PubMed ID: 9607372
[TBL] [Abstract][Full Text] [Related]
13. Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
Wombolt DG; Jackson A; Punn R; Smith S; McCune TR; Williams PB
J Clin Pharmacol; 1999 Mar; 39(3):310-2. PubMed ID: 10073331
[No Abstract] [Full Text] [Related]
14. The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris.
Charlon V; Kobrin I
Int J Clin Pract; 1998 Jun; 52(4):257-64. PubMed ID: 9744152
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonist: introduction.
Giles TD
Am J Cardiol; 1997 Aug; 80(4B):1C-3C. PubMed ID: 9286847
[No Abstract] [Full Text] [Related]
16. Mibefradil release expands calcium-channel-blocker choices.
Am J Health Syst Pharm; 1997 Sep; 54(18):2033. PubMed ID: 9377200
[No Abstract] [Full Text] [Related]
17. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
18. Potential cardioprotective effect of mibefradil in the long-term treatment of hypertension.
Waeber B
Cardiology; 1998; 89 Suppl 1():16-22. PubMed ID: 9570425
[TBL] [Abstract][Full Text] [Related]
19. Mibefradil: a selective T-type calcium antagonist.
Massie BM
Am J Cardiol; 1997 Nov; 80(9A):23I-32I. PubMed ID: 9375939
[TBL] [Abstract][Full Text] [Related]
20. Chronic T-type Ca2+ channel blockade with mibefradil in hyperinsulinemic, insulin-resistant and hypertensive rats.
Verma S; Bhanot S; Hicke A; McNeill JH
Cardiovasc Res; 1997 Apr; 34(1):121-8. PubMed ID: 9217881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
